{
    "eid": "2-s2.0-84900496801",
    "title": "Sustained complete response after maintenance therapy with topotecan and erlotinib for recurrent cervical cancer with distant metastases",
    "cover-date": "2014-01-01",
    "subject-areas": [
        {
            "$": "Oncology",
            "@code": "2730"
        }
    ],
    "keywords": [
        "Epidermal growth factor receptor inhibitor",
        "Erlotinib",
        "Maintenance therapy",
        "Recurrent cervical cancer"
    ],
    "authors": [
        "Donato Callegaro-Filho"
    ],
    "citedby-count": 2,
    "ref-count": 13,
    "ref-list": [
        "Global cancer statistics",
        "Recurrent squamous cell carcinoma of cervix after definitive radiotherapy",
        "Chemotherapy for recurrent cervical cancer",
        "J Clin Oncol",
        "Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial",
        "Erlotinib in previously treated non-small-cell lung cancer",
        "Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: A multicentre, randomised, placebo-controlled phase 3 study",
        "Randomized, phase III study of gemcitabine or erlotinib maintenance therapy versus observation,with predefined second-line treatment, after cisplatin-gemcitabine induction chemotherapy in advanced non-small-cell lung cancer",
        "Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group",
        "Oncogene alterations in carcinomas of the uterine cervix: Overexpression of the epidermal growth factor receptor is associated with poor prognosis",
        "Transcriptional regulation of the EGF receptor promoter by HPV16 and retinoic acid in human ectocervical epithelial cells",
        "A Phase II trial of erlotinib in recurrent squamous cell carcinoma of the cervix",
        "J Clin Oncol"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Sao Paulo",
            "affilname": "Hospital Israelita Albert Einstein",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Houston",
            "affilname": "The University of Texas MD Anderson Cancer Center",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}